AlzeCure Pharma
Stockholm
About AlzeCure Pharma
The AlzeCure Foundation is focused on the development of novel diagnostics and therapeutics for PD, AD and related neurodegenerative disorders. Conceptually, AlzeCure is an industry-standard incubator for novel projects. It comprises key professionals exhibiting complementary expertise from molecule to man.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $6.3M
- Funding stage: IPO
- Last round: Grant (Dec 2025)
- Ticker: sto:ALZCUR
- Website: alzecurepharma.sesv
- Phone: +46 (0) 703-73 88 24.
Industries & Categories
Health Care, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/alzecure-pharma-138712 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.